Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Markus Ackerknecht"'
Autor:
Walter P. Weber, Zoltan Matrai, Stefanie Hayoz, Christoph Tausch, Guido Henke, Daniel R. Zwahlen, Günther Gruber, Frank Zimmermann, Stefanie Seiler, Charlotte Maddox, Thomas Ruhstaller, Simone Muenst, Markus Ackerknecht, Sherko Kuemmel, Vesna Bjelic-Radisic, Christian Kurzeder, Mihály Újhelyi, Conny Vrieling, Rok Satler, Inna Meyer, Charles Becciolini, Susanne Bucher, Colin Simonson, Peter M. Fehr, Natalie Gabriel, Robert Maráz, Dimitri Sarlos, Konstantin J. Dedes, Cornelia Leo, Gilles Berclaz, Peter Dubsky, Ruth Exner, Hisham Fansa, Christopher Hager, Klaus Reisenberger, Christian F. Singer, Roland Reitsamer, Mattea Reinisch, Jelena Winkler, Giang Thanh Lam, Mathias K. Fehr, Tatiana Naydina, Magdalena Kohlik, Karine Clerc, Valerijus Ostapenko, Florian Fitzal, Rahel Nussbaumer, Nadia Maggi, Alexandra Schulz, Pagona Markellou, Loïc Lelièvre, Daniel Egle, Jörg Heil, Michael Knauer
Publikováno v:
Breast, Vol 60, Iss , Pp 98-110 (2021)
Aim: We developed tailored axillary surgery (TAS) to reduce the axillary tumor volume in patients with clinically node-positive breast cancer to the point where radiotherapy can control it. The aim of this study was to quantify the extent of tumor lo
Externí odkaz:
https://doaj.org/article/a6afce6f79f449a0a15b5200378bb924
Autor:
Guido Henke, Michael Knauer, Karin Ribi, Stefanie Hayoz, Marie-Aline Gérard, Thomas Ruhstaller, Daniel R. Zwahlen, Simone Muenst, Markus Ackerknecht, Hanne Hawle, Florian Fitzal, Michael Gnant, Zoltan Mátrai, Bettina Ballardini, Andreas Gyr, Christian Kurzeder, Walter P. Weber
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-28 (2018)
Abstract Background Complete lymph node removal through conventional axillary dissection (ALND) has been standard treatment for breast cancer patients for almost a century. In the 1990s, however, and in parallel with the advent of the sentinel lymph
Externí odkaz:
https://doaj.org/article/1a682dd8f81a449b9c03eb01c8e53636
Autor:
Walter P. Weber, Zoltan Matrai, Stefanie Hayoz, Guido Henke, Daniel R. Zwahlen, Günther Gruber, Frank Zimmermann, Thomas Ruhstaller, Simone Muenst, Markus Ackerknecht, Christian Kurzeder, Sherko Küemmel, Vesna Bjelic-Radisic, Viktor Smanykó, Conny Vrieling, Rok Satler, Inna Meyer, Charles Becciolini, Susanne Bucher, Colin Simonson, Peter M. Fehr, Natalie Gabriel, Robert Maráz, Dimitri Sarlos, Konstantin J. Dedes, Cornelia Leo, Gilles Berclaz, Hisham Fansa, Christopher Hager, Klaus Reisenberger, Ákos Sávolt, Christian F. Singer, Roland Reitsamer, Jelena Winkler, Giang Thanh Lam Lam, Mathias K. Fehr, Tatiana Naydina, Magdalena Kohlik, Karine Clerc, Valerijus Ostapenko, Florian Fitzal, Martin Heidinger, Nadia Maggi, Alexandra Schulz, Pagona Markellou, Loïc Lelièvre, Daniel Egle, Jörg Heil, Michael Knauer, Christoph Tausch
Publikováno v:
Cancer Research. 83:P2-14
Introduction: Even though randomized controlled trials could not show a significant survival benefit for the use of neoadjuvant systemic therapy (NST), it is increasingly recommended for patients with clinically node-positive breast cancer due to its
Autor:
Mattea Reinisch, Dimitri Sarlos, Peter M. Fehr, Simone Muenst, Susanne Bucher, Gilles Berclaz, Magdalena Kohlik, Colin Simonson, Mihály Újhelyi, Peter Dubsky, Cornelia Leo, Inna Meyer, Karine Clerc, Walter P. Weber, Nadia Maggi, Mathias K. Fehr, Loïc Lelièvre, Christopher Hager, Markus Ackerknecht, Jelena Winkler, Jörg Heil, Sherko Kuemmel, Michael Knauer, Guido Henke, Thomas Ruhstaller, Christian Kurzeder, Ruth Exner, Natalie Gabriel, Frank Zimmermann, Klaus Reisenberger, Christian F. Singer, Günther Gruber, Zoltan Matrai, Conny Vrieling, Hisham Fansa, Vesna Bjelic-Radisic, Alexandra Schulz, Roland Reitsamer, Tatiana Naydina, Valerijus Ostapenko, Giang Thanh Lam, Charles Becciolini, Konstantin J. Dedes, Robert Maráz, Rok Satler, Pagona Markellou, Daniel R. Zwahlen, Charlotte Maddox, Stefanie Seiler, Stefanie Hayoz, Rahel Nussbaumer, Daniel Egle, Florian Fitzal, Christoph Tausch
Publikováno v:
The Breast : Official Journal of the European Society of Mastology
Breast, Vol 60, Iss, Pp 98-110 (2021)
Breast, Vol 60, Iss, Pp 98-110 (2021)
Aim We developed tailored axillary surgery (TAS) to reduce the axillary tumor volume in patients with clinically node-positive breast cancer to the point where radiotherapy can control it. The aim of this study was to quantify the extent of tumor loa
Autor:
Walter P. Weber, Zoltan Matrai, Stefanie Hayoz, Christoph Tausch, Guido Henke, Daniel R. Zwahlen, Günther Gruber, Frank Zimmermann, Thomas Ruhstaller, Simone Muenst, Markus Ackerknecht, Sherko Küemmel, Vesna Bjelic-Radisic, Viktor Smanykó, Conny Vrieling, Rok Satler, Inna Meyer, Charles Becciolini, Susanne Bucher, Colin Simonson, Peter M. Fehr, Natalie Gabriel, Robert Maráz, Dimitri Sarlos, Konstantin J. Dedes, Cornelia Leo, Gilles Berclaz, Hisham Fansa, Christopher Hager, Klaus Reisenberger, Ákos Sávolt, Christian F. Singer, Roland Reitsamer, Jelena Winkler, Giang Thanh Lam Lam, Mathias K. Fehr, Tatiana Naydina, Magdalena Kohlik, Karine Clerc, Valerijus Ostapenko, Florian Fitzal, Martin Heidinger, Nadia Maggi, Alexandra Schulz, Pagona Markellou, Loïc Lelièvre, Daniel Egle, Jörg Heil, Michael Knauer, Christian Kurzeder
Publikováno v:
Cancer Research. 83:PD15-11
Introduction: Chemotherapy is recommended for patients with luminal breast cancer and more than three positive nodes. In addition, recent landmark trials raised the question if the exact number of positive nodes is required to indicate genomic testin
Autor:
James Sharpe, Jens V. Stein, Yoshinori Fukui, Jim Swoger, Jun Abe, Kathrin Gollmer, Markus Ackerknecht, Philipp Germann, Jorge Ripoll, Xenia Ficht
Publikováno v:
The Journal of Immunology. 199:520-530
Parenchymal migration of naive CD4+ T cells in lymph nodes (LNs) is mediated by the Rac activator DOCK2 and PI3Kγ and is widely assumed to facilitate efficient screening of dendritic cells (DCs) presenting peptide-MHCs (pMHCs). Yet how CD4+ T cell m
Autor:
Daniel R. Zwahlen, Andreas Gyr, Markus Ackerknecht, Karin Ribi, Michael Knauer, Christian Kurzeder, Hanne Hawle, Zoltan Matrai, Thomas Ruhstaller, Michael Gnant, Simone Muenst, Marie Aline Gérard, Bettina Ballardini, Florian Fitzal, Guido Henke, Walter P. Weber, Stefanie Hayoz
Publikováno v:
Trials
Trials, Vol 19, Iss 1, Pp 1-28 (2018)
Trials, Vol 19, Iss 1, Pp 1-28 (2018)
Background Complete lymph node removal through conventional axillary dissection (ALND) has been standard treatment for breast cancer patients for almost a century. In the 1990s, however, and in parallel with the advent of the sentinel lymph node (SLN
Autor:
Christoph Tausch, Mihály Újhelyi, Stefanie Seiler, Walter P. Weber, Stefanie Hayoz, Guido Henke, Michael Knauer, Simone Muenst, Charlotte Maddox, Thomas Ruhstaller, Zoltán Mátrai, Loïc Lelièvre, Markus Ackerknecht, Daniel R. Zwahlen, Jörg Heil, Christian Kurzeder, Karin Ribi, Daniel Egle, Florian Fitzal
Publikováno v:
Cancer Research. 81:PD4-04
Introduction: We developed tailored axillary surgery (TAS) to selectively remove positive nodes and omit axillary lymph node dissection (ALND) in patients with clinically node-positive breast cancer irrespective of the use of neoadjuvant chemotherapy
Autor:
Daniel R. Zwahlen, Walter P. Weber, Loïc Lelièvre, Mihály Újhelyi, Zoltán Mátrai, Thomas Ruhstaller, Michael Knauer, Christian Kurzeder, Stefanie Seiler, Charlotte Maddox, Markus Ackerknecht, Stefanie Hayoz, Karin Ribi, Jörg Heil, Guido Henke, Simone Muenst, Christoph Tausch, Florian Fitzal, Daniel Egle
Publikováno v:
Cancer Research. 81:OT-04
Background Main weaknesses of neoadjuvant chemotherapy (NACT) to avoid axillary dissection (ALND) in patients with clinically node-positive breast cancer are frequent failure of achieving nodal pathologic complete response (pCR) and administration of
Autor:
Markus, Ackerknecht, Kathrin, Gollmer, Philipp, Germann, Xenia, Ficht, Jun, Abe, Yoshinori, Fukui, Jim, Swoger, Jorge, Ripoll, James, Sharpe, Jens V, Stein
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 199(2)
Parenchymal migration of naive CD4